Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323313128> ?p ?o ?g. }
- W4323313128 endingPage "645" @default.
- W4323313128 startingPage "645" @default.
- W4323313128 abstract "Subjects with type 2 diabetes mellitus (T2D) are at increased risk for heart failure (HF). The cardiac-specific (FABP3) and adipose-tissue-specific (FABP4) types of the fatty acid binding proteins have been associated with both all-cause and cardiovascular (CV) mortality. The aim of this study was to explore the prognosis value of FABP3 and FABP4 in ambulatory subjects with chronic HF (CHF), with and without T2D. A prospective study involving 240 ambulatory CHF subjects was performed. Patients were followed-up for a mean of 5.78 ± 3.30 years and cause of death (if any) was recorded. Primary endpoints were defined as all-cause and CV death, and a composite endpoint that included CV death or hospitalization for HF was included as a secondary endpoint. Baseline serum samples were obtained and the serum FABP3 and FABP4 concentrations were assessed by sandwich enzyme-linked immunosorbent assay. Survival analysis was performed with multivariable Cox regressions, using Fine and Gray competing risks models when needed, to explore the prognostic value of FABP3 and FABP4 concentrations, adjusting for potential confounders. Type 2 diabetes mellitus was highly prevalent, accounting for 47.5% for total subjects with CHF. Subjects with T2D showed higher mortality rates (T2D: 69.30%; non-T2D: 50.79%, p = 0.004) and higher serum FABP3 (1829.3 (1104.9-3440.5) pg/mL vs. 1396.05 (820.3-2362.16) pg/mL, p = 0.007) and FABP4 (45.5 (27.6-79.8) ng/mL vs. 34.1 (24.09-55.3) ng/mL, p = 0.006) concentrations compared with non-T2D CHF subjects. In the whole study cohort, FABP3 was independently associated with all-cause death, and both FABP3 and FABP4 concentrations were associated with CV mortality. The predictive values of these two molecules for all-cause (FABP3: HR 1.25, 95% CI 1.09-1.44; p = 0.002. FABP4: HR 2.21, 95% CI 1.12-4.36; p = 0.023) and CV mortality (FABP3: HR 1.28, 95% CI 1.09-1.50; p = 0.002. FABP4: HR 4.19, 95% CI 2.21-7.95; p < 0.001) were only statistically significant in the subgroup of subjects with T2D. Notably, FABP4 (HR 2.07, 95% CI 1.11-3.87; p = 0.022), but not FABP3, also predicted the occurrence of the composite endpoint (death or hospitalization for HF) only in subjects with T2D. All these associations were not found in CHF subjects without T2D. Our findings support the usefulness of serum FABP3 and FABP4 concentrations as independent predictors for the occurrence of all-cause and CV mortality in ambulatory subjects with CHF with T2D." @default.
- W4323313128 created "2023-03-07" @default.
- W4323313128 creator A5002466407 @default.
- W4323313128 creator A5012291664 @default.
- W4323313128 creator A5016571179 @default.
- W4323313128 creator A5016593285 @default.
- W4323313128 creator A5017682728 @default.
- W4323313128 creator A5040190129 @default.
- W4323313128 creator A5047847326 @default.
- W4323313128 creator A5051072429 @default.
- W4323313128 creator A5053204320 @default.
- W4323313128 creator A5057374991 @default.
- W4323313128 creator A5067093821 @default.
- W4323313128 creator A5068386601 @default.
- W4323313128 creator A5072060157 @default.
- W4323313128 creator A5088203341 @default.
- W4323313128 creator A5091859232 @default.
- W4323313128 date "2023-03-04" @default.
- W4323313128 modified "2023-10-14" @default.
- W4323313128 title "Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus" @default.
- W4323313128 cites W1522100208 @default.
- W4323313128 cites W1728581005 @default.
- W4323313128 cites W173298670 @default.
- W4323313128 cites W1965551253 @default.
- W4323313128 cites W1966467934 @default.
- W4323313128 cites W1972102243 @default.
- W4323313128 cites W1973688956 @default.
- W4323313128 cites W1975408288 @default.
- W4323313128 cites W1983800482 @default.
- W4323313128 cites W1985969855 @default.
- W4323313128 cites W1987015387 @default.
- W4323313128 cites W2018693309 @default.
- W4323313128 cites W2018903719 @default.
- W4323313128 cites W2022296599 @default.
- W4323313128 cites W2023606650 @default.
- W4323313128 cites W2024172364 @default.
- W4323313128 cites W2025004005 @default.
- W4323313128 cites W2025372788 @default.
- W4323313128 cites W2027985570 @default.
- W4323313128 cites W2032218212 @default.
- W4323313128 cites W2038722300 @default.
- W4323313128 cites W2045139389 @default.
- W4323313128 cites W2056357418 @default.
- W4323313128 cites W2059565408 @default.
- W4323313128 cites W2095876186 @default.
- W4323313128 cites W2096431106 @default.
- W4323313128 cites W2101408894 @default.
- W4323313128 cites W2103679597 @default.
- W4323313128 cites W2105265053 @default.
- W4323313128 cites W2115192091 @default.
- W4323313128 cites W2124624517 @default.
- W4323313128 cites W2125868425 @default.
- W4323313128 cites W2126495538 @default.
- W4323313128 cites W2135239854 @default.
- W4323313128 cites W2136974237 @default.
- W4323313128 cites W2139563543 @default.
- W4323313128 cites W2141101573 @default.
- W4323313128 cites W2143239235 @default.
- W4323313128 cites W2150561315 @default.
- W4323313128 cites W2151843848 @default.
- W4323313128 cites W2154455571 @default.
- W4323313128 cites W2156683561 @default.
- W4323313128 cites W2160388497 @default.
- W4323313128 cites W2167216129 @default.
- W4323313128 cites W2169507034 @default.
- W4323313128 cites W2172210299 @default.
- W4323313128 cites W2180443235 @default.
- W4323313128 cites W2215365016 @default.
- W4323313128 cites W2463991149 @default.
- W4323313128 cites W2511161488 @default.
- W4323313128 cites W2529245971 @default.
- W4323313128 cites W2548455412 @default.
- W4323313128 cites W2606419213 @default.
- W4323313128 cites W2752440002 @default.
- W4323313128 cites W2762066682 @default.
- W4323313128 cites W2777850814 @default.
- W4323313128 cites W2803218851 @default.
- W4323313128 cites W2883666216 @default.
- W4323313128 cites W2887613806 @default.
- W4323313128 cites W2939757174 @default.
- W4323313128 cites W3006902162 @default.
- W4323313128 cites W3014893962 @default.
- W4323313128 cites W3126188458 @default.
- W4323313128 cites W3130548558 @default.
- W4323313128 cites W3139261217 @default.
- W4323313128 cites W3142187620 @default.
- W4323313128 cites W4249896096 @default.
- W4323313128 cites W4292528167 @default.
- W4323313128 doi "https://doi.org/10.3390/antiox12030645" @default.
- W4323313128 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36978893" @default.
- W4323313128 hasPublicationYear "2023" @default.
- W4323313128 type Work @default.
- W4323313128 citedByCount "0" @default.
- W4323313128 crossrefType "journal-article" @default.
- W4323313128 hasAuthorship W4323313128A5002466407 @default.
- W4323313128 hasAuthorship W4323313128A5012291664 @default.
- W4323313128 hasAuthorship W4323313128A5016571179 @default.
- W4323313128 hasAuthorship W4323313128A5016593285 @default.